A challenging strategy for the prevention of cardiovascular risk

We know that the greater the number of risk factors, the CV risk increases. Intervention in risk factors is crucial and the guidelines recommend that the calculation of cardiovascular risk and its stratification should be used and carried out in all consultations.

Evidence has been shown that the fixed combination of a statin (Atorvastatin) + Perindopril + Amlodipine decreases cardiovascular risk by 80%. Statins should be a routine therapy in hypertensive patients with increased cardiovascular risk

SCAC 04/23 DM 216 SERVIER - For the exclusive use of the health care professional.